---
title: 'Understanding iron homeostasis in MDS: the role of erythroferrone'
date: '2024-06-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38835379/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240605181437&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Myelodysplastic neoplasms (MDS) are a heterogenous group of clonal stem
  cell disorders characterized by dysplasia and cytopenia in one or more cell lineages.
  Anemia is a very common symptom that is often treated with blood transfusions and/or
  erythropoiesis stimulating factors. Iron overload results from a combination of
  these factors together with the disease-associated ineffective erythropoiesis, that
  is seen especially in MDS cases with SF3B1 mutations. A growing body of research
  has ...
disable_comments: true
---
Myelodysplastic neoplasms (MDS) are a heterogenous group of clonal stem cell disorders characterized by dysplasia and cytopenia in one or more cell lineages. Anemia is a very common symptom that is often treated with blood transfusions and/or erythropoiesis stimulating factors. Iron overload results from a combination of these factors together with the disease-associated ineffective erythropoiesis, that is seen especially in MDS cases with SF3B1 mutations. A growing body of research has ...